The current financial score of Acadia Healthcare Company Inc is 7.60. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 895.31M, representing a year-over-year increase of 5.14%, while its net profit experienced a year-over-year increase of 4.86%.
The current valuation score of Acadia Healthcare Company Inc is 7.68. Its current P/E ratio is -2.85, which is -1090.51% below the recent high of 28.24 and -40533.83% above the recent low of -1158.35.
The current earnings forecast score of Acadia Healthcare Company Inc is 7.29. The average price target is 0.00, with a high of 0.00 and a low of 0.00.
The current price momentum score of Acadia Healthcare Company Inc is 5.16. Currently, the stock price is trading between the resistance level at 40.00 and the support level at 28.94, making it suitable for range-bound swing trading.
The current institutional shareholding score of Acadia Healthcare Company Inc is 10.00. The latest institutional shareholding proportion is 133.17%, representing a quarter-over-quarter decrease of 6.86%.
The current risk assessment score of Acadia Healthcare Company Inc is 5.60. The company's beta value is 0.71. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.